Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

Identical to MIB1. ‡ Gastrointestinal neuroendocrine tumor. § Pancreatic neuroendocrine tumor. NET: Neuroendocrine tumor. Data from [20,94]. T1 Tumor limited to the pancreas and size <2 cm T2 ...

Jennifer Chan, MD, MPH, discussed the recent FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine ...

With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer ...

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

Exelixis (NASDAQ:EXEL) said on Wednesday that the U.S. FDA has approved cabozantinib for patients 12 years of age and older ...

Neuroendocrine tumors that start in the pancreas tend to be more aggressive and have a poor prognosis.

Germline and Somatic Testing Guidelines and Challenges Guidelines now recommend germline panel testing for all patients diagnosed with pancreatic cancer (excluding neuroendocrine tumors), regardless ...

There is also a much rarer form of pancreatic cancer which develops from islet cells in the pancreas and is known as ...

This is your stage. Doctors use your stage to plan your treatment. There are different ways to stage pancreatic neuroendocrine cancer. Doctors usually use the TNM system or number stages. There are 4 ...

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited ... M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and ...

The FDA approved cabozantinib for previously treated, unresectable, locally advanced or metastatic, well-differentiated ...